DE69200365T2 - Pharmazeutische Zusammensetzung zur Verbesserung von Dysuria. - Google Patents

Pharmazeutische Zusammensetzung zur Verbesserung von Dysuria.

Info

Publication number
DE69200365T2
DE69200365T2 DE69200365T DE69200365T DE69200365T2 DE 69200365 T2 DE69200365 T2 DE 69200365T2 DE 69200365 T DE69200365 T DE 69200365T DE 69200365 T DE69200365 T DE 69200365T DE 69200365 T2 DE69200365 T2 DE 69200365T2
Authority
DE
Germany
Prior art keywords
denotes
carbon atoms
alkyl group
dysuria
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69200365T
Other languages
English (en)
Other versions
DE69200365D1 (de
Inventor
Yuko Morioka
Mitsuru Takano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Publication of DE69200365D1 publication Critical patent/DE69200365D1/de
Application granted granted Critical
Publication of DE69200365T2 publication Critical patent/DE69200365T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69200365T 1991-12-10 1992-12-10 Pharmazeutische Zusammensetzung zur Verbesserung von Dysuria. Expired - Fee Related DE69200365T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3325458A JP2549480B2 (ja) 1991-12-10 1991-12-10 排尿障害改善剤

Publications (2)

Publication Number Publication Date
DE69200365D1 DE69200365D1 (de) 1994-10-06
DE69200365T2 true DE69200365T2 (de) 1995-02-16

Family

ID=18177097

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69200365T Expired - Fee Related DE69200365T2 (de) 1991-12-10 1992-12-10 Pharmazeutische Zusammensetzung zur Verbesserung von Dysuria.

Country Status (18)

Country Link
US (1) US5496823A (de)
EP (1) EP0546547B1 (de)
JP (1) JP2549480B2 (de)
KR (1) KR930012019A (de)
CN (1) CN1073861A (de)
AT (1) ATE110569T1 (de)
AU (1) AU656443B2 (de)
CA (1) CA2084962A1 (de)
CZ (1) CZ282422B6 (de)
DE (1) DE69200365T2 (de)
DK (1) DK0546547T3 (de)
ES (1) ES2062860T3 (de)
HU (2) HU9203911D0 (de)
IL (1) IL104026A (de)
MX (1) MX9207123A (de)
PH (1) PH30691A (de)
TW (1) TW210286B (de)
ZA (1) ZA929529B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780476A (en) * 1992-11-16 1998-07-14 Cell Therapeutics, Inc. Hydroxyl-containing xanthine compounds
DE19529102A1 (de) * 1995-08-08 1997-02-13 Kummer Horst Dieter Verwendung von PDE-Inhibitoren bei der Behandlung von Harnblasenerkrankungen
CA2266070A1 (en) * 1996-09-19 1998-03-26 American Home Products Corporation Method of treating urinary incontinence
US20220054494A1 (en) * 2019-03-13 2022-02-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods for treating bladder and urethra dysfunction and disease
WO2021065027A1 (ja) 2019-10-02 2021-04-08 あすか製薬株式会社 排尿障害改善剤
MX2022003983A (es) 2019-10-02 2022-04-26 Aska Pharm Co Ltd Agente mejorador de los trastornos de la miccion.
WO2022131354A1 (ja) 2020-12-18 2022-06-23 あすか製薬株式会社 固形製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤

Also Published As

Publication number Publication date
ES2062860T3 (es) 1994-12-16
MX9207123A (es) 1993-07-30
CZ282422B6 (cs) 1997-07-16
KR930012019A (ko) 1993-07-20
JPH05155773A (ja) 1993-06-22
CA2084962A1 (en) 1993-06-11
CZ361192A3 (en) 1993-09-15
ZA929529B (en) 1993-06-15
DK0546547T3 (da) 1995-02-13
DE69200365D1 (de) 1994-10-06
IL104026A (en) 1995-11-27
CN1073861A (zh) 1993-07-07
AU656443B2 (en) 1995-02-02
EP0546547B1 (de) 1994-08-31
IL104026A0 (en) 1993-05-13
EP0546547A1 (de) 1993-06-16
AU2998592A (en) 1993-06-17
PH30691A (en) 1997-09-16
TW210286B (de) 1993-08-01
US5496823A (en) 1996-03-05
JP2549480B2 (ja) 1996-10-30
HUT63055A (en) 1993-07-28
HU9203911D0 (en) 1993-03-29
ATE110569T1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
ATE174899T1 (de) Zytotoxische stilben-derivate und diese enthaltende pharmazeutische zusammensetzungen
DE69531502D1 (de) Monoamid, diamid, thiol enthaltende metall-chelatierende verbindungen
DE68917023T2 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
GR3022631T3 (en) Trifluoromethylketone derivatives of peptides having HLE inhibiting activity, their preparation and pharmaceutical composition
MX9709475A (es) Derivados de pirrol y composicion medicinal.
NO152047C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksom 5-(paradeuterofenyl)-5-fenylhydantoin
TW261616B (de)
EP0682009A3 (de) Zwischenprodukte für die Herstellung von Endothelinrezeptor-Antagonist-Triterpen-Derivaten.
EP0572635A4 (de) Verbindungen met Guanidin Struktur und diese enthaltende pharmazeutische Zusammenstellungen.
DE69200365T2 (de) Pharmazeutische Zusammensetzung zur Verbesserung von Dysuria.
GR3020233T3 (en) Use of xanthine derivatives for the manufacture of a medicament for the treatment of secondary nerve cell damages and function disorders after head-brain-traumata
YU86792A (sh) Rastvor sparfloksacina, njegovo dobijanje i so sparfloksacina kao komponenta rastvora
KR950701612A (ko) 포타슘 채널 오프너 및 요실금 치료제로서의 알콜(alcohols as potassium channel openers and in treatment of urinary inconitnence)
RS50033B (sr) Derivati etansulfonil-piperidina
IT1147330B (it) Medicamento,o preparato farmaceutico,ad azione citostatica
AU2224795A (en) Ameliorant or remedy for paraneoplastic syndrome
TW360630B (en) A secoaporphine compounds on arrhythmia
DE69528984T2 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
ES8500619A1 (es) Procedimiento de preparacion de derivados de eburnano-oxima racemicos u opticamente activos.
RU92004490A (ru) Фармацевтическая композиция для лечения дизурии и способ ее лечения

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee